
SLNO
Healthcare · Biotechnology · $2.76B market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2026
EPS trend, 90 days to now · -4.7% over 90 days · 30-day revisions 0 up, 3 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 12, 2026 | Time not confirmed | 0.68 | 0.59 | -13.2% |
| Mar 11, 2026 | Time not confirmed | 0.21 | 0.80 | +272.1% |
| Nov 4, 2025 | Time not confirmed | 0.05 | 0.47 | +840.0% |
| Aug 6, 2025 | Time not confirmed | -0.64 | -0.09 | +85.9% |
| Jun 6, 2025 | After the close | -0.93 | -0.95 | -2.4% |
| Mar 4, 2025 | Before the open | -1.08 | -1.27 | -17.9% |
| Nov 5, 2024 | Before the open | -0.63 | -1.83 | -190.5% |
| Aug 7, 2024 | After the close | -0.60 | -0.57 | +5.0% |
| May 9, 2024 | After the close | -0.37 | -0.59 | -59.5% |
| Mar 6, 2024 | After the close | -0.27 | -0.33 | -22.2% |
| Nov 7, 2023 | Before the open | -0.58 | -0.95 | -63.8% |
| Aug 8, 2023 | After the close | -0.83 | -0.81 | +2.4% |
| May 9, 2023 | After the close | -0.72 |
Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was…
| -0.88 |
| -22.2% |
| Mar 21, 2023 | After the close | -0.80 | -0.58 | +27.5% |
| Nov 9, 2022 | After the close | -0.91 | -0.76 | +16.5% |
| Aug 10, 2022 | After the close | -0.90 | -0.90 | 0.0% |
| May 10, 2022 | After the close | -1.05 | -1.08 | -2.9% |
| Mar 31, 2022 | After the close | -1.27 | -0.60 | +52.8% |
| Nov 10, 2021 | After the close | -1.65 | -1.50 | +9.1% |
| Jul 28, 2021 | After the close | -1.60 | -2.10 | -31.3% |
| May 5, 2021 | After the close | -1.15 | -1.65 | -43.5% |
| Mar 3, 2021 | After the close | -1.05 | -0.60 | +42.9% |
| Nov 10, 2020 | After the close | -1.30 | -1.65 | -26.9% |
| Aug 10, 2020 | After the close | -3.07 | -2.40 | +21.8% |
| May 12, 2020 | After the close | -2.95 | -1.95 | +33.9% |
| Mar 4, 2020 | After the close | -2.40 | -5.40 | -125.0% |
| Nov 13, 2019 | Before the open | -2.40 | 0.45 | +118.8% |
| Aug 7, 2019 | After the close | -2.62 | -4.65 | -77.5% |
| May 13, 2019 | Before the open | -4.35 | -3.30 | +24.1% |
| Mar 18, 2019 | Before the open | -4.35 | -1.20 | +72.4% |
| Nov 14, 2018 | After the close | -3.22 | -1.95 | +39.4% |
| Aug 14, 2018 | After the close | -3.67 | -5.40 | -47.1% |
| Apr 2, 2018 | Before the open | -3.45 | -7.95 | -130.4% |
| Mar 16, 2018 | Time not confirmed | -0.23 | -0.53 | -130.4% |